Brief Title:Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac Surgery
NCT ID: NCT01534364
Last Updated: 2019-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2012-01-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pre-operative Exposure to SGLT2 Inhibitors and Post-operative Acute Renal Failure in Cardiac Surgery
NCT06432751
Development of Ketoacidosis During the Perioperative Period: an Observational Study 'The DKAP Study'
NCT05225467
Pre-operative Exposure to SGLT2 Inhibitors and Post-operative Acute Renal Failure in Cardiac Surgery: a Retrospective Monocentric Cohort Study
NCT06453161
The Impact of Vitamin C on Postoperative Acute Kidney Injury in Risk Patients Undergoing Valvular Heart Surgery
NCT04210453
Impact of Preoperative Nutritional Status on the Postoperative Mortality and Morbidity in Patients Undergoing Valvular Heart Surgery
NCT04307732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary objective is the increase of serum creatinine in mg/dl 24 h after induction of ischemia ("cross clamping") in comparison to baseline value obtained in the morning of the day of surgery (day 0) in order to analyse if a preoperative calorie restriction as a preventive strategy leads to a attenuation of postoperative kidney injury. Hypothesis: A seven day calorie restriction reduces the increase of serum creatinine after cardiac surgery in patients with known chronic kidney disease.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
Ad libitum alimentation
No interventions assigned to this group
calorie restriction
Calorie Restriction to 60% of the calculated daily energy rate from day -7 until day -1 (included) pre-surgery day 0 corresponds to day of surgery)
calorie restriction
Calorie Restriction to 60% of the calculated daily energy rate from day -7 until day -1 (included) pre-surgery (day 0 corresponds to day of surgery)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
calorie restriction
Calorie Restriction to 60% of the calculated daily energy rate from day -7 until day -1 (included) pre-surgery (day 0 corresponds to day of surgery)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Caucasian origin
3. Scheduled cardiothoracic operation with employment of cardio-pulmonary bypass and a lead time of 11 days minimum.
4. Indication for cardiac surgery is determined by the cardiothoracic specialist
5. Patient and/or legal guardian must be willing and able to give written informed consent
6. one of the following risk factors:
1. serum creatinine \>1,1 mg/dl in male and \> 0,9 mg/dl in female
2. type 2 diabetes
3. peripheral artery occlusive disease
4. heart failure with NYHA III-IV (ejection fraction \< 50 %)
5. combined CABG and heart valve surgery
6. further surgery after CABG or heart valve surgery
Exclusion Criteria
2. Indwelling kidney transplant
3. Malnutrition (BMI \< 18,5 kg/m2)
4. Body weight \< 46 kg in male and \< 51 kg in female
5. BMI \> 35 kg/m2 or body weight \> 120 kg
6. Catabolic state (serum albumine \< 25 g/l)
7. Diet within the previous 4 weeks
8. Inappetence
9. Weight loss \> 1 kg within the previous 2 weeks, if not explained by use of diuretics
10. Hospital stay during the last 7 days prior to cardiac surgery
11. Consuming underlying disease
12. Uncontrolled local or systemic infection
13. Contraindication for enteral nutrition.
14. Known allergy against or incompatibility with ingredients of the employed formula-diet
15. Pregnancy or breast feeding
16. Participation in other interventional clinical trials.
17. Missing safe method of contraception or missing occurence of menopause (in female)
18. Professional or private relationship between subject and the investigators or dependence on the investigators.
19. Placement in an institution based on official orders.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fresenius Kabi
INDUSTRY
University of Cologne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Volker Burst
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Volker Burst, MD
Role: PRINCIPAL_INVESTIGATOR
University of Cologne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cologne
Cologne, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Grundmann F, Muller RU, Reppenhorst A, Hulswitt L, Spath MR, Kubacki T, Scherner M, Faust M, Becker I, Wahlers T, Schermer B, Benzing T, Burst V. Preoperative Short-Term Calorie Restriction for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Open-Label, Pilot Trial. J Am Heart Assoc. 2018 Mar 13;7(6):e008181. doi: 10.1161/JAHA.117.008181.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00003355
Identifier Type: REGISTRY
Identifier Source: secondary_id
001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.